Envivo Bio Inc
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan (NCT07054593) | Envivo Bio Inc | 2025-12-01 |
| Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan® (NCT06298409) | Envivo Bio Inc | 2024-02-15 |
| Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine (NCT05749068) | Envivo Bio Inc | 2022-09-01 |
Track Envivo Bio Inc automatically
Every clearance here is in the API, with alerts when new ones post.